Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Bullish on Sight Sciences Increases Price Target to 7

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_Assets
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

Stifel analyst Thomas Stephan is bullish on Sight Sciences (NASDAQ: SGHT) and has increased the price target from $6 to $7, citing a promising future for the company. The consensus target price for Sight Sciences stands at $7, with an average target price of $5.625, indicating strong analyst confidence in the company’s potential. Despite market fluctuations, analysts remain optimistic about Sight Sciences’ performance. The company currently holds a consensus rating of Hold, with 1 buy rating and 4 hold ratings, and an average price target of $4.50.

SGHT Stock Shows Positive Price Momentum: What Investors Need to Know

On March 8, 2024, SGHT stock showed positive price momentum as it closed the day with a 3.48% increase in its share price. Despite the positive price momentum, SGHT is currently trading in the middle of its 52-week range and below its 200-day simple moving average. The $0.16 increase in SGHT shares may be a positive sign for investors, but it is important to consider the overall trend of the stock. Investors should also consider other factors such as company performance, industry trends, and market conditions when evaluating SGHT stock. It is important to conduct thorough research and analysis before making any investment decisions to ensure that they align with your financial goals and risk tolerance.

SGHT Stock Performance Analysis: Revenue Increases, Net Loss Narrows, and EPS Improves

On March 8, 2024, SGHT stock showed mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $81.06 million for the past year, with a slight increase of 13.63% compared to the previous year. However, the total revenue remained flat at $18.75 million for the last quarter.

In terms of net income, SGHT reported a net loss of -$55.55 million for the past year, which was an improvement of 35.59% compared to the previous year. The net income for the last quarter was reported at -$10.69 million, showing no change from the previous quarter.

Earnings per share (EPS) for SGHT also showed an improvement, with a reported EPS of -$1.14 for the past year, which was an increase of 36.62% compared to the previous year. The EPS for the last quarter was reported at -$0.22, showing an increase of 18.37% compared to the previous quarter.

Overall, while SGHT showed improvements in net income and EPS compared to the previous year, the total revenue remained flat for the last quarter. Investors may want to closely monitor the company’s financial performance in the coming quarters.

Tags: SGHT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Retailers Stock Market Today

Analyst Steven Shemesh Reaffirms Positive Outlook on Albertsons Companies

Healthcare-and-IT

Boston Scientific A Decade of Exceptional Growth and Wealth Generation

Finance_Assets (2)

Analyst Ratings and Price Targets for T Rowe Price Group

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com